Case Study: a Dutch biotechnology company strengthens FDA regulatory readiness with FREYR’s USDMF submission support

Dutch Biotechnology Company strengthens FDA readiness with FREYR through a 4-step USDMF submission process

A Dutch biotechnology company required assistance with preparing, reviewing, and submitting a US Drug Master File (USDMF) to the FDA. With limited internal bandwidth, they needed expert support to organize the documentation and align it with FDA expectations. They engaged Freyr for its regulatory support services to achieve a compliant submission process.

Freyr supported the client by structuring and preparing the DMF documentation, performing a quality review, and facilitating its submission to the FDA. This solution strengthened the client's regulatory readiness, improved the quality and structure of their submission, and provided a clearer pathway for future regulatory interactions.